BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spin Diagnostics, Inc. Presents At Southwest Bio Venture Conference


10/19/2005 5:09:29 PM

AUSTIN, Texas, Dec. 10 /PRNewswire/ -- CN Group and Texas Healthcare and Bioscience Institute announced that Dr. Shishir Shah, president of Spin Diagnostics, will be presenting today at the fourth annual Southwest Bio Venture Conference & Symposium. Shah is scheduled to outline the company's breakthrough SICAP technology that is revolutionizing the field of cellular analysis by combining flow cytometry with high-throughput microscopy, and a unique use of gravity.

The company is developing the next generation of instrumentation capable of high-throughput, high-content screening: analyzing living and dead cells, body fluids, and cellular constituents that will be used in the research market for drug discovery programs and the clinical markets for disease diagnosis. The core technology platform supports a universal format for sample handling and provides unprecedented capability in high-throughput imaging and analysis of cells and its constituents at speeds that are 10- to 100-fold faster than existing technologies.

The Southwest Bio Venture Conference & Symposium, currently being held at the Hyatt Regency in Houston, features select visionaries and expert keynote speakers. Spin Diagnostic will be among 15 of the best life science, biotech, medical and healthcare prospects for venture capital investments in Texas and the Southwestern United States. The event is being attended by 450 attendees, representing some of the country's leading venture capital firms, angels and strategic corporate investment executives.

"The initial impact of Spin Diagnostics' products will be on the markets of high-throughout high-content screening; flow cytometry; adsorption, distribution, metabolism, excretion (ADME) and toxicology profiling; and clinical diagnostics," said Shah. The early users will include pharmaceuticals, biotechnology and basic research institutions. Because high- content systems provide several answers simultaneously with a significant reduction in time and costs, it simply makes sense to gather as much information as possible from each screen or assay. Currently, the biggest obstacle to adopting high-content systems in the existing discovery and research processes is speed. Spin has already solved this problem."

About Spin Diagnostics

Spin Diagnostics was founded in March 2002 and is headquartered in Houston, Texas. Headed by Dr. Shishir Shah, the company has completed prototype development and has demonstrated the technology's validity and advantages in high throughput cellular analysis. Beta testing of the research line of SICAP products is under way with collaborators at two independent research institutions. The company plans on introducing its first instrument along with consumables in the second quarter of 2004.

For additional information, please contact Dr. Shishir Shah at 281-333-0009, or by e-mail at sshah@spindiagnostics.com .

About CN Group

CN Group helps build growth companies through three business efforts. CN Events produces the leading Venture Capital, Private Equity and Angel Investor gatherings in the Southwest. CN Management Services assists companies in building their management team and Board and Advisory Boards. Capital Network Securities, an NASD-approved investment bank, provides merger and acquisition advisory services, and capital-raising services for select growth companies. For more information please visit http://www.cngroupllc.com/ .

About Texas Healthcare and Bioscience Institute

Texas Healthcare and Bioscience Institute (THBI) is a public policy research organization whose members consist of biotechnology, medical device, and pharmaceutical companies; academic and private research institutions; chambers of commerce; and local and regional economic development foundations. The mission of THBI is to research, develop and advocate policies that promote life science innovation in Texas. For more information, visit http://www.thbi.com/ .

Media Contact: Patti D. Hill BlabberMouth Public Relations (512) 528 - 0201 patti@blabbermouthPR.com

CN Group; Texas Healthcare and Bioscience Institute

CONTACT: Patti D. Hill of BlabberMouth Public Relations,+1-512-528-0201, or patti@blabbermouthPR.com , for CN Group



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES